SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Godard P et al. Asthma: a disease remodelling the airways? Allergy 1992;47:311.
  • 2
    Laprise C, Sladek R, Ponton A, Bernier MC, Hudson TJ, Laviolette M. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics 2004;23:2131.
  • 3
    Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V et al. Airway remodeling in asthma. Chest 2003;123:417422.
  • 4
    Howarth PH, Wilson J, Bousquet J, Rak S, Pauwels R (editors). Airway remodelling. Series LenfantC. Lung biology in health and disease series. New York: Marcel Dekker, Inc., 2001.
  • 5
    Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:17201745.
  • 6
    Bousquet J, Jacot W, Yssel H, Vignola AM, Humbert M. Epigenetic inheritance of fetal genes in allergic asthma. Allergy 2004;59:138147.
  • 7
    Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003;58:691706.
  • 8
    Braunstahl GJ, Fokkens W. Nasal involvement in allergic asthma. Allergy 2003;58:12351243.
  • 9
    Bousquet J, Jacquot W, Vignola AM, Bachert C, Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004;113:4349.
  • 10
    Watelet JB, Van Cauwenberge P. Applied anatomy and physiology of the nose and paranasal sinuses. Allergy 1999;54(Suppl. 57):1425.
  • 11
    Tos M. Goblet cells and glands in the nose and paranasal sinuses. In: ProctorD, AndersenI, editors. The nose. Amsterdam: Elsevier Biomedical Press, 1982:99144.
  • 12
    Friedmann J. Structure and function: nose, throat and ears. In: SymmersWSC, editor. Systemic pathology. New-York, USA: Churchill Livingstone, 1986:313.
  • 13
    Toppozada HA, Talaat MA. The normal human maxillary sinus mucosa. An electron microscopic study. Acta Otolaryngol (Stockh) 1980;89:204213.
  • 14
    Arey LB. Human histology, 4th edn. Philadelphia: WB Saunders, 1974.
  • 15
    Lindemann J, Keck T, Wiesmiller K, Sander B, Brambs HJ, Rettinger G et al. A numerical simulation of intranasal air temperature during inspiration. Laryngoscope 2004;114:10371041.
  • 16
    Redington AE. Fibrosis and airway remodelling. Clin Exp Allergy 2000;30(Suppl. 1):4245.
  • 17
    Watelet JB, Bachert C, Gevaert P, Van Cauwenberge P. Wound healing of the nasal and paranasal mucosa: a review. Am J Rhinol 2002;16:7784.
  • 18
    Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF. Fibroblast migration in fibrin gel matrices. Am J Pathol 1993;142:273283.
  • 19
    Rudack C, Hermann W, Eble J, Schroeder JM. Neutrophil chemokines in cultured nasal fibroblasts. Allergy 2002;57:11591164.
  • 20
    Pierce GF. Macrophages: important physiologic and pathologic source of polypeptide growth factors. Am J Respir Cell Mol Biol 1990;2:233234.
  • 21
    Wilhem DL. Regeneration of tracheal epithelium. J Pathol Bacteriol 1953;65:543550.
  • 22
    Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993;73:161195.
  • 23
    Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448464.
  • 24
    Watelet JB, Demetter P, Claeys C, Van Cauwenberge P, Cuvelier C, Bachert C. Wound healing after paranasal sinus surgery: neutrophilic inflammation influences the outcome. Histopathology 2006;48:174181.
  • 25
    Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Rep Reg 2004;12:412418.
  • 26
    Watelet JB, Demetter P, Claeys C, Van Cauwenberge P, Cuvelier C, Bachert C. Neutrophil-derived MMP-9 predicts the healing quality after sinus surgery. Laryngoscope 2005;115:5661.
  • 27
    Sali RJ, Howarth PH. Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease? Clin Exp Allergy 2003;33:16291633.
  • 28
    Salib RJ, Drake-Lee A, Howarth PH. Allergic rhinitis: past, present and the future. Clin Otolaryngol 2003;28:291303.
  • 29
    Sanai A, Nagata H, Konno A. Extensive interstitial collagen deposition on the basement membrane zone in allergic nasal mucosa. Acta Otolaryngol 1999;119:473478.
  • 30
    Abrams DC, Toynton SC, Dore C, Emson MA, Taylor P, Springall DR et al. Stereological estimation of blood vessel surface and volume densities in human normal and rhinitic nasal mucosa. Rhinology 1997;35:2227.
  • 31
    Watanabe K, Kiuna C. Epithelial damage of nasal mucosa in nasal allergy. Ann Otol Rhinol Laryngol 1998;107:564570.
  • 32
    Montero Mora P, Blanco E, Matta Campos JJ, Gonzales Espinosa A, Guidos Folgelbach G, Tinajeros Castaneda OA. Nasal remodeling in patient with perennial allergic rhinitis. Rev Alerg Mex 2003;50:7982.
  • 33
    Chanez P, Vignola AM, Vic P, Guddo F, Bonsignore G, Godard P et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159:588595.
  • 34
    Austin CE, Foreman JC, Scadding GK. Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage. Br J Pharmacol 1994;111:969971.
  • 35
    Kirmaz C, Ozbilgin K, Yuksel H, Bayrak P, Unlu H, Giray G et al. Expression of angiogenic markers in patients with seasonal allergic rhinitis. Eur Cytokine Netw 2004;15:317322.
  • 36
    Kang HJ, Kang JS, Lee SH, Hwang SJ, Chae SW, Woo JS et al. Upregulation of oncostatin m in allergic rhinitis. Laryngoscope 2005;115:22132216.
  • 37
    Saetti R, Sivestrini M, Cutrone C, Barion U, Mirri L, Narne S. Endoscopic treatment of upper airway and digestive tract lesions caused by caustic agents. Ann Otol Rhinol Laryngol 2003;112:2936.
  • 38
    Cayé-Thomassen P, Hermansson A, Tos M, Prellner K. Pathogenesis of middle ear adhesions. Laryngoscope 1996;106:463469.
  • 39
    Paund S, Lund V, Gallimore A. Nasal fibrosis: long-term follow-up of four cases of eosinophilic angiocentric fibrosis. J Laryngol Otol 2005;119:119124.
  • 40
    Fokkens W, Lund V, Bachert C, Clement P, Hellings P, Holmstrom M et al. European position paper on rhinosinusitis and nasal polyps. Rhinology 2005;43(Suppl. 18):87.
  • 41
    Fokkens W, Lund V, Bachert C, Clement P, Hellings P, Holmstrom M et al. EAACI position paper on rhinosinusitis and nasal polyps: executive summary. Allergy 2005;60:583601.
  • 42
    Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffrey TA, Tarara BA et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003;112:877882.
  • 43
    Meltzer EO, Hamilos DL, Hadley JA, Lanza DJ, Marple BF, Nicklas RA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol, 2004;114:S155S212.
  • 44
    Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59:5460.
  • 45
    Fritz SB, Terrel JE, Conner ER, Kukowska-Latallo JF, Baker JR. Nasal mucosal gene expression in patients with allergic rhinitis with or without nasal polyps. J Allergy Clin Immunol 2003;112:10571063.
  • 46
    Kakoi H, Hiraide F. A histological study of formation and growth of nasal polyps. Acta Otolaryngol 1987;103:137144.
  • 47
    Altuntas A, Yilmaz MD, Aktepe F, Kahveci OK, Derekoy S, Dilek H et al. Expression and distribution of aquaporin-1 in nasal polyps: does it have any significance in edema formation? Am J Rhinol 2006;20:128131.
  • 48
    Varga EM, Jacobson MR, Masuyama K, Rak S, Till SJ, Darby Y et al. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J 1999;14:610615.
  • 49
    Pawankar R. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy 2005;87:111129.
  • 50
    Lechapt-Zalcman E, Escudier E. Implication of extracellular matrix metalloproteinases in the course of chronic inflammatory airway diseases. Morphologie 2000;84:4549.
  • 51
    Bhandari A, Takeuchi K, Suzuki S, Harada T, Hayashi S, Imanaka-Yoshida K et al. Increased expression of matrix metalloproteinase-2 in nasal polyps. Acta Otolaryngol 2004;124:11651170.
  • 52
    Kostamo K, Sorsa T, Leino M, Tervahartiala T, Alenius H, Richardson M et al. In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis. Allergy 2005;60:12751279.
  • 53
    Maldonado M, Martinez A, Alobid I, Mullol J. The antrochoanal polyp. Rhinology 2004;42:178182.
  • 54
    Cepero R, Smith RJ, Catlin FI, Bressler KL, Furuta GT, Shandera KC. Cystic fibrosis and otolaryngologic perspectives. Otolaryngol Head Neck Surg 1987;97:356360.
  • 55
    Wilson JW, Robertson CF. Angiogenesis in paediatric airway disease. Paediatr Respir Rev 2002;3:219229.
  • 56
    Ratjen F, Hartog CM, Paul K, Wermelt J, Braun J. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax 2002;57:930934.
  • 57
    Shute J, Marshall L, Bodey K, Bush A. Growth factors in cystic fibrosis: when more is not enough. Paediatr Respir Rev 2003;4:120127.
  • 58
    Hays SR, Ferrando RE, Carter R, Wong HH, Woodruff PG. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 2005;60:226228.
  • 59
    Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Verhasselt B et al. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005;35:467472.
  • 60
    Lund V, Milroy CM. Fronto-ethmoidal mucocoeles: a histopathological analysis. J Laryngol Otol 1991;105:921923.
  • 61
    Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111(Suppl. 1):S18S34.
  • 62
    Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108116.
  • 63
    Jung TT, Juhn SK, Hwang D, Stewart R. Prostaglandins, leukotrienes and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987;97:184189.
  • 64
    Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:11891196.
  • 65
    Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004;113:277283.
  • 66
    Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913921.
  • 67
    Jantii-Alanco S, Holopainen E, Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinology 1989;8:5964.
  • 68
    Kowalski ML, Bienkiewicz B, Kordek P, Pawliczak R. Nasal polyposis in aspirin-hypersensitive patients with asthma and aspirin-tolerant patients. J World Allergy Org 2003;15:246250.
  • 69
    Kowalski ML, Pawliczak R, Woźniak J, Siuda K, Poniatowska M, Iwaszkiewicz J et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000;161:391398.
  • 70
    Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol 2004;114:814819.
  • 71
    Vancheri C, Mastruzzo C, Trovato-Salinaro E, Gili E, Lo Furno D, Pistorio MP et al. Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells. Respir Res 2005;13:103116.
  • 72
    Weber KT. Metabolic response of extracellular matrix in tissue repair. Ann Med 1997;29:333338.
  • 73
    Knight D. Epithelium-fibroblast interactions in response to airway inflammation. Immunol Cell Biol 2001;79:160164.
    Direct Link:
  • 74
    Zeisberg M, Strutz F, Muller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 2000;13(Suppl. 3):S111S120.
  • 75
    Westergren-Thorsson G, Chakir J, Lafreniere-Allard MJ, Boulet LP, Tremblay GM. Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol 2002;34:12561267.
  • 76
    Terada N, Hamano N, Nomura T, Numata T, Hirai K, Nakajima T et al. Interleukin-13 and tumour necrosis factor-alpha synergically induce eotaxin production in human nasal fibroblasts. Clin Exp Immunol 2000;30:348355.
  • 77
    Lambert E, Dasse E, Hayes B, Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004;49:187198.
  • 78
    Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28S38.
  • 79
    Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:13011315.
  • 80
    Sobol SE, Fukakusa M, Christodoulopoulos P, Manoukian JJ, Schloss MD, Frenkiel S et al. Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 2003;113:410414.
  • 81
    Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004;114:9971008.
  • 82
    Takayashi N, Yamada T, Narita N, Fujieda S. Double-stranded RNA induces production of RANTES and IL-8 by human nasal fibroblasts. Clin Immunol 2006;118:5158.
  • 83
    Sun D, Matsume S, Ohori J, Fukuiwa T, Ushikai M, Kurono Y. TNF-alpha and endotoxins increase hypoxia-induced VEGF production by cultured human nasal fibroblasts in synergistic fashion. Auris Nasus Larynx 2005;32:243249.
  • 84
    Psarras S, Volonaki E, Skevaki CL, Xatzipsalti M, Bossios A, Pratsinis H et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol 2006;117:291297.
  • 85
    Nonaka M, Pawankar R, Fukumoto A, Ogihara N, Sakanushi A, Yagi T. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts. Clin Exp Allergy 2004;34:804811.
  • 86
    Steinke JW, Crouse CD, Bradley D, Hise K, Lynch K, Kountakis SE et al. Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 2004;30:212219.
  • 87
    Yeh TH, Hsu WC, Chen YS, Hsu CJ, Lee SY. Decreased connexin 43 expression correlated with eosinophil infiltration in nasal polyps. Am J Rhinol 2005;19:5964.
  • 88
    Liu CM, Hong CY, Shun CT, Hsiao TY, Wang CC, Wang JS et al. Inducible cyclooxygenase and interleukin 6 gene expressions in nasal polyp fibroblasts: possible implication in the pathogenesis of nasal polyposis. Arch Head Neck Surg 2002;128:945951.
  • 89
    Danielsen A, Tynning T, Brokstad KA, Olofsson J, Davidsson A. Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Frackalkine in human nasal polyps, turbinate mucosa and serum. Eur Arch Otorhinolaryngol 2006;263:282289.
  • 90
    Rudack C, Stoll W, Hermann W. Primary nasal epithelial cells and fibroblasts have inflammation-inducing functions. HNO 2003;51:480485.
  • 91
    Shun CT, Lin SK, Hong CY, Kok SH, Juan YH, Wang CC et al. C-C chemokine ligand 2 gene expression in nasal polyp fibroblasts: possible implication in the pathogenesis of nasal polyposis. An Otol Rhinol Laryngol 2005;114:879885.
  • 92
    Busuttil A, More IA, Mc Seveney D. Ultrastructure of the stroma of nasal polyps: cilia in stromal fibroblasts. Arch Otolaryngol 1976;102:589595.
  • 93
    Umbach B, Hennebach U. Changes in connective tissue metabolism in fibroblasts from nasal polyps. HNO 1994;42:344349.
  • 94
    Haruna S, Nakanishi M, Otori N, Moriyama H. Histopathological features of nasal polyps with asthma association: an immunohistochemical study. Am J Rhinol 2004;18:165172.
  • 95
    Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone proprionate. Laryngoscope 2003;113:18031812.
  • 96
    Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep 2005;5:463471.
  • 97
    Serpero L, Petecchia L, Sabatini F, Giuliani M, Silvestri M, Di Blasi P et al. The effect of transforming growth factor (TGF)-beta(1) and (TGF)-beta(2) on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 2006;105:6167.
  • 98
    Tewfik MA, Bernardes JF, Shan J, Robinson M, Frenkiel S, Eidelman DH. Nitric oxide and collagen expression in allergic upper-airway disease. Am J Rhinol 2003;17:269274.
  • 99
    Caye-Thomassen P, Larsen K, Tingsgaard P, Tos M. Basic fibroblast growth factor expression in recurrent versus non-recurrent nasal polyposis. Eur Arch Otorhinolaryngol 2004;261:321325.
  • 100
    Yariktas M, Doner F, Stcu R, Demirci M, Dogru H, Yasan H. The effect of topical corticosteroid on basic fibroblast growth factor in nasal polyp tissue. Am J Rhinol 2005;19:248250.
  • 101
    Uchida J, Kanai K, Asano K, Watanabe S, Hisamitsu T, Suzaki H. Influence of fluticasone proprionate on the production of vascular endothelial growth factor and basic fibroblast growth factor from nasal fibroblasts in vitro. In Vivo 2004;18:767770.
  • 102
    Hirano S, Asano K, Namba M, Kanai K, Hisamitsu T, Suzaki H. Induction of apoptosis in nasal polyp fibroblasts by glucocorticoids in vitro. Acta Otolaryngol 2003;123:10751079.
  • 103
    Cagnoni F, Oddera S, Semino C, Mincarini M, Melioli G, Canonica GW. Cetirizine-induced downregulation of airway fibroblast proliferation and function: a rationale for a different approach to allergy treatment? Immunol Lett 2000;72:3134.
  • 104
    Beata RN, Wojcieh F, Stanislaw S, Ryszard M. The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps. Auris Nasus Larynx 2005;32:225229.
  • 105
    Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 2004;23:671678.
  • 106
    Namba M, Asano K, Kanai K, Kyo Y, Watanabe S, Hisamitsu T et al. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone proprionate in vitro. Acta Otolaryngol 2004;124:964969.